Accessibility Menu
 
bioMérieux logo

bioMérieux

(OTC) BMXMF

Current Price$82.75
Market Cap$9.76B
Since IPO (2004)+125%
5 Year-28%
1 Year-36%
1 Month-19%

bioMérieux Financials at a Glance

Market Cap

$9.76B

Revenue (TTM)

$8.05B

Net Income (TTM)

$829.41M

EPS (TTM)

$3.80

P/E Ratio

21.62

Dividend

$1.03

Beta (Volatility)

0.27 (Low)

Price

$82.75

Volume

105

Open

$82.91

Previous Close

$82.75

Daily Range

$82.75 - $82.91

52-Week Range

$77.38 - $152.00

BMXMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About bioMérieux

Industry

Healthcare Equipment and Supplies

Employees

15,078

CEO

Pierre Boulud

Headquarters

Marcy l'Étoile, 69280, FR

BMXMF Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

10%

Net Income Margin

10%

Return on Equity

10%

Return on Capital

9%

Return on Assets

7%

Earnings Yield

4.63%

Dividend Yield

1.24%

Payout Ratio

26.71%

Stock Overview

Market Cap

$9.76B

Shares Outstanding

117.99M

Volume

105

Avg. Volume

83.619

Financials (TTM)

Gross Profit

$2.14B

Operating Income

$560.99M

EBITDA

$999.23M

Operating Cash Flow

$788.00M

Capital Expenditure

$335.17M

Free Cash Flow

$452.83M

Cash & ST Invst.

$569.59M

Total Debt

$461.23M

bioMérieux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.03B

+6.3%

Gross Profit

$992.43M

+2.2%

Gross Margin

49.00%

N/A

Market Cap

$9.76B

N/A

Market Cap/Employee

$690.15K

N/A

Employees

14,147

N/A

Net Income

$236.21M

+20.5%

EBITDA

$475.72M

-0.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$108.36M

+165.1%

Accounts Receivable

$1.01B

+38.7%

Inventory

$959.34M

+5.6%

Long Term Debt

$329.88M

-7.2%

Short Term Debt

$131.35M

-19.6%

Return on Assets

7.13%

N/A

Return on Invested Capital

8.61%

N/A

Free Cash Flow

$288.09M

+163.1%

Operating Cash Flow

$470.62M

+58.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICLRICON Public Limited Company
$112.85-4.63%
CRLCharles River Laboratories International, Inc.
$165.78-0.71%
GHGuardant Health, Inc.
$87.60+0.60%
TWSTTwist Bioscience Corporation
$60.40+3.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
NIONio
$5.91-0.08%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.22-0.03%

Questions About BMXMF

What is the current price of bioMérieux?

bioMérieux is trading at $82.75 per share.

What is the 52-week range for bioMérieux?

Over the past 52 weeks, bioMérieux has traded between $77.38 and $152.00.

How much debt does bioMérieux have?

As of the most recent reporting period, bioMérieux reported total debt of $541.89M.

How much cash does bioMérieux have on hand?

bioMérieux reported $669.20M in cash and cash equivalents in its most recent financial results.

What is bioMérieux’s dividend yield?

bioMérieux currently has a dividend yield of 1.24%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.